173 related articles for article (PubMed ID: 25872931)
1. Effect and mechanism of poly (ADP-ribose) polymerase-1 in aldosterone-induced apoptosis.
Qiao W; Zhang W; Shao S; Gai Y; Zhang M
Mol Med Rep; 2015 Aug; 12(2):1631-8. PubMed ID: 25872931
[TBL] [Abstract][Full Text] [Related]
2. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells.
Sha Y; Zhou W; Yang Z; Zhu X; Yang X; Li TD; Zhu D
Toxicol Mech Methods; 2015; 25(6):467-77. PubMed ID: 26335980
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity.
Kim J; Long KE; Tang K; Padanilam BJ
Kidney Int; 2012 Jul; 82(2):193-203. PubMed ID: 22437413
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis.
Wang J; Hao L; Wang Y; Qin W; Wang X; Zhao T; Liu Y; Sheng L; Du Y; Zhang M; Lu Q
Mol Med Rep; 2015 Mar; 11(3):1768-76. PubMed ID: 25412407
[TBL] [Abstract][Full Text] [Related]
6. Minocycline inhibits PARP‑1 expression and decreases apoptosis in diabetic retinopathy.
Wu Y; Chen Y; Wu Q; Jia L; Du X
Mol Med Rep; 2015 Oct; 12(4):4887-94. PubMed ID: 26165350
[TBL] [Abstract][Full Text] [Related]
7. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.
Patel AG; Flatten KS; Schneider PA; Dai NT; McDonald JS; Poirier GG; Kaufmann SH
J Biol Chem; 2012 Feb; 287(6):4198-210. PubMed ID: 22158865
[TBL] [Abstract][Full Text] [Related]
8. The activity and inhibition of poly(ADP-ribose) polymerase-1 in equine peripheral blood mononuclear cells in vitro.
Douglas HF; Southwood LL; Meyer-Ficca ML; Hart SK; Meyer RG
J Vet Emerg Crit Care (San Antonio); 2015; 25(4):528-37. PubMed ID: 26040949
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells.
Kuang J; Wang YL; Xiao M; Tang Y; Chen WW; Song GL; Yang X; Li M
Oncol Rep; 2014 May; 31(5):2335-43. PubMed ID: 24676941
[TBL] [Abstract][Full Text] [Related]
11. PARP1 during embryo implantation and its upregulation by oestradiol in mice.
Joshi A; Mahfooz S; Maurya VK; Kumar V; Basanna CS; Kaur G; Hanif K; Jha RK
Reproduction; 2014 Jun; 147(6):765-80. PubMed ID: 24516177
[TBL] [Abstract][Full Text] [Related]
12. Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy.
Yang M; Liu L; Xie M; Sun X; Yu Y; Kang R; Yang L; Zhu S; Cao L; Tang D
Autophagy; 2015; 11(2):214-24. PubMed ID: 25607248
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin resistance associated with PARP hyperactivation.
Michels J; Vitale I; Galluzzi L; Adam J; Olaussen KA; Kepp O; Senovilla L; Talhaoui I; Guegan J; Enot DP; Talbot M; Robin A; Girard P; Oréar C; Lissa D; Sukkurwala AQ; Garcia P; Behnam-Motlagh P; Kohno K; Wu GS; Brenner C; Dessen P; Saparbaev M; Soria JC; Castedo M; Kroemer G
Cancer Res; 2013 Apr; 73(7):2271-80. PubMed ID: 23554447
[TBL] [Abstract][Full Text] [Related]
14. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway.
Robaszkiewicz A; Valkó Z; Kovács K; Hegedűs C; Bakondi E; Bai P; Virág L
Free Radic Biol Med; 2014 Nov; 76():69-79. PubMed ID: 25078118
[TBL] [Abstract][Full Text] [Related]
15. Reduced ADP-ribosylation by PARP1 natural polymorphism V762A and by PARP1 inhibitors enhance Hepatitis B virus replication.
Ko HL; Ng HJ; Goh EH; Ren EC
J Viral Hepat; 2013 Sep; 20(9):658-65. PubMed ID: 23910651
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade.
Shang F; Zhang J; Li Z; Zhang J; Yin Y; Wang Y; Marin TL; Gongol B; Xiao H; Zhang YY; Chen Z; Shyy JY; Lei T
PLoS One; 2016; 11(3):e0151845. PubMed ID: 26986624
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase 1 inhibition protects human aortic endothelial cells against LPS-induced inflammation response.
Peng X; Li W; Zhang W
Acta Biochim Biophys Sin (Shanghai); 2012 Nov; 44(11):911-7. PubMed ID: 23027378
[TBL] [Abstract][Full Text] [Related]
19. Probing PARP1-inhibitor complexes for the development of novel inhibitors.
Saqib U; Baig MS
Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):43-52. PubMed ID: 25346248
[TBL] [Abstract][Full Text] [Related]
20. PARP1 Val762Ala polymorphism reduces enzymatic activity.
Wang XG; Wang ZQ; Tong WM; Shen Y
Biochem Biophys Res Commun; 2007 Mar; 354(1):122-6. PubMed ID: 17214964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
